CM
Caption Management Portfolio holdings
AUM $1.09B
1-Year Return
4.13%
This Quarter Return
+2.11%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$1.09B
AUM Growth
-$1.1B
(-50%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-110.09%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,115
New
230
Increased
115
Reduced
111
Closed
247
Top Buys
| 1 |
Insmed
INSM
|
+$21.2M |
| 2 |
SKX
Skechers
SKX
|
+$20.1M |
| 3 |
Gilead Sciences
GILD
|
+$16.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 5 |
Kellanova
K
|
+$14.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$394M |
| 2 |
Amazon
AMZN
|
+$314M |
| 3 |
NVIDIA
NVDA
|
+$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$130M |
| 5 |
Cisco
CSCO
|
+$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.45% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.35T
| $95.3M | 1.05% |
300,000
+4,000
| +1% | +$1.27M |
|
|
2
Alphabet (Google) Class C
GOOG
$3T
| $40.2M | 0.44% |
226,397
-307,028
| -58% | -$54.5M |
|
3
Soleno Therapeutics
SLNO
$2.71B
| $22.1M | 0.24% |
263,287
-31,713
| -11% | -$2.66M |
|
|
4
Insmed
INSM
$30.6B
| $21.2M | 0.24% |
+210,928
| New | +$21.2M |
|
|
SKX
5
DELISTED
Skechers
SKX
| $20.1M | 0.22% |
+317,932
| New | +$20.1M |
|
|
6
Gilead Sciences
GILD
$139B
| $16.5M | 0.18% |
+148,600
| New | +$16.5M |
|
|
7
Regeneron Pharmaceuticals
REGN
$62.1B
| $16.4M | 0.18% |
+31,200
| New | +$16.4M |
|
|
8
Kellanova
K
$27.6B
| $15M | 0.17% |
188,281
+187,145
| +16,474% | +$14.9M |
|
9
iShares MSCI India ETF
INDA
$9.53B
| $14.2M | 0.16% |
+255,280
| New | +$14.2M |
|
10
Galicia Financial Group
GGAL
$4.87B
| $13.9M | 0.15% |
275,708
+28,206
| +11% | +$1.42M |
|
11
Mastercard
MA
$538B
| $13.3M | 0.15% |
+23,700
| New | +$13.3M |
|
12
Cidara Therapeutics
CDTX
$1.65B
| $13.1M | 0.14% |
+268,000
| New | +$13.1M |
|
13
Starbucks
SBUX
$95.4B
| $12M | 0.13% |
+131,000
| New | +$12M |
|
14
Visa
V
$667B
| $11.4M | 0.13% |
32,000
| – | – |
|
15
ARK Innovation ETF
ARKK
$9.24B
| $10.9M | 0.12% |
154,700
-7,400
| -5% | -$520K |
|
16
Janux Therapeutics
JANX
$1.46B
| $10.6M | 0.12% |
457,012
+412,569
| +928% | +$9.53M |
|
17
Boot Barn
BOOT
$5.54B
| $10.3M | 0.11% |
68,000
+45,500
| +202% | +$6.92M |
|
18
Arvinas
ARVN
$572M
| $9.88M | 0.11% |
1,343,029
+1,279,329
| +2,008% | +$9.42M |
|
|
CBL
19
CBL Properties
CBL
$973M
| $8.81M | 0.1% |
347,059
-97,551
| -22% | -$2.48M |
|
20
Vistra
VST
$70.7B
| $8.72M | 0.1% |
45,000
+34,300
| +321% | +$6.65M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.83B
| $8.64M | 0.1% |
237,500
+58,672
| +33% | +$2.13M |
|
22
Henry Schein
HSIC
$8.27B
| $8.62M | 0.1% |
118,000
+111,138
| +1,620% | +$8.12M |
|
23
Nice
NICE
$9.14B
| $8.52M | 0.09% |
+50,416
| New | +$8.52M |
|
24
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$956M
| $8.15M | 0.09% |
751,544
+251,544
| +50% | +$2.73M |
|
25
Natera
NTRA
$24.2B
| $7.6M | 0.08% |
+45,000
| New | +$7.6M |
|